Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VC Roundup: Flagship’s New Fund Designed To Raise Its Stake In Startups

Executive Summary

Newly renamed Flagship Pioneering has raised a $285m venture capital fund to remain invested in portfolio companies as they grow. Also, 12 new and growing biopharma companies raised $657.15m.

Advertisement

Related Content

Rubius Prepares Off-The-Shelf Red Cell Therapies For First Human Trial In 2018
IPO Update: TiGenix Debuts In December After Motif Launched In November As 2016 Offerings Best 2015
Bayer/Versant Launch New Stem Cell Company With Massive Cash Injection
New CNS-Focused Biotech Cerevance Launches With Takeda Backing
Kymab Keeps Cash Coming In With $100m Led By Chinese Investors
Moderna Prepares For mRNA Drug R&D Blitz With $474m In New Equity
Denali Builds Neurodegeneration Pipeline Through Discovery, Collaborations And Lots Of Cash
Early February VC Tally: 6 Biotech Firms Raise $153.5m
Can Editas, BeiGene Offerings Redeem US IPO Class Of 2015?
Biotech benefits as VC firms raise cash in Q2

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097928

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel